Published in Infect Immun on January 01, 1981
Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect Immun (1985) 4.56
Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology (1986) 3.33
Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages. J Clin Microbiol (1986) 2.94
I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages. Clin Exp Immunol (1985) 2.73
Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun (1987) 2.42
Lymphokines enhance the capacity of human monocytes to secret reactive oxygen intermediates. J Clin Invest (1982) 2.23
Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages. Antimicrob Agents Chemother (1994) 1.60
Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of gamma interferon. Infect Immun (1989) 1.52
MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages. Antimicrob Agents Chemother (1993) 1.50
Interaction of human leukocytes and Entamoeba histolytica. Killing of virulent amebae by the activated macrophage. J Clin Invest (1985) 1.49
Mycobacterial antigen-specific human T-cell clones secreting macrophage activating factors. Immunology (1985) 1.36
Relative permissiveness of macrophages from black and white people for virulent tubercle bacilli. Infect Immun (1990) 1.32
Progress in the immunology of the mycobacterioses. Clin Exp Immunol (1987) 1.31
Cytokine regulation of the intracellular growth of Mycobacterium paratuberculosis in bovine monocytes. Infect Immun (1988) 1.29
Ingestion and intracellular growth of Mycobacterium paratuberculosis within bovine blood monocytes and monocyte-derived macrophages. Infect Immun (1987) 1.20
Growth of Mycobacterium avium in activated macrophages harvested from inbred mice with differing innate susceptibilities to mycobacterial infection. Infect Immun (1988) 1.13
Radiolabelled M. leprae resident in human macrophage cultures as an in vitro indicator of effective immunity in human leprosy. Clin Exp Immunol (1982) 1.04
Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin. Antimicrob Agents Chemother (1993) 0.98
Immunization against tuberculosis: what kind of vaccine? Infect Immun (1988) 0.94
Evans blue dye adjuvant enhances delayed hypersensitivity while blocking immunity to Mycobacterium tuberculosis in mice. Infect Immun (1981) 0.88
Macrophage migration inhibitory factor reduces the growth of virulent Mycobacterium tuberculosis in human macrophages. Infect Immun (2005) 0.88
Virulent Mycobacterium fortuitum restricts NO production by a gamma interferon-activated J774 cell line and phagosome-lysosome fusion. Infect Immun (2002) 0.85
Mycobacteria infect different cell types in the human lung and cause species dependent cellular changes in infected cells. BMC Pulm Med (2016) 0.77
Effects of ascent to high altitude on human antimycobacterial immunity. PLoS One (2013) 0.77
The separation, long-term cultivation, and maturation of the human monocyte. J Exp Med (1977) 4.46
Interaction between phagocytes and pathogenic microorganisms. Bacteriol Rev (1956) 4.29
The growth of intracellular tubercle bacilli in relation to their virulence. Am Rev Tuberc (1954) 2.92
Macrophages in resistance to rickettsial infection: macrophage activation in vitro for killing of Rickettsia tsutsugamushi. J Immunol (1979) 2.34
Conditions for production, and some characteristics, of mycobacterial growth inhibitory factor produced by spleen cells from mice immunized with viable cells of the attenuated H37Ra strain of Mycobacterium tuberculosis. Infect Immun (1975) 1.83
The role of thymus-derived lymphocytes in the in vitro activation of macrophages to kill Listeria monocytogenes. J Immunol (1973) 1.82
Cellular antimicrobial immunity. CRC Crit Rev Microbiol (1978) 1.62
Incorporation of tritiated thymidine by leprosy bacilli in cultures of human lepromatous macrophages. J Infect Dis (1972) 1.54
Primary cultures of macrophages from normal human peripheral blood. Lab Invest (1962) 1.49
Experiments on lymphocyte-mediated cellular immunity in murine histoplasmosis. Infect Immun (1977) 1.29
The regulation of thymidine secretion by macrophages. J Immunol (1979) 1.02
Molecular weight and other characteristics of mycobacterial growth inhibitory factor produced by spleen cells obtained from mice immunized with viable attenuated mycobacterial cells. Infect Immun (1975) 0.97
Tubercle bacillary extracts immunogenic for mice. 2. Water-soluble proteinaceous extracts. Tubercle (1961) 0.96
A hanging drop macrophage function test. J Reticuloendothel Soc (1978) 0.93
Macrophage migration inhibitory activity of mycobacterial growth inhibitory factor and the effect of a number of factors on mycobacterial growth inhibitory factor activity. Infect Immun (1975) 0.92
Partial characterization of a factor extracted from sensitized lymphocytes that inhibits the growth of Mycobacterium tuberculosis within macrophages in vitro. Infect Immun (1976) 0.91
Quantitative evaluation of the progress of intracellular infection in vitro: incorporation of 3H-thymidine into deoxyribonucleic acid by Mycobacterium leprae in cultivated blood monocytes. Infect Immun (1974) 0.88
Primary cultures of human spleen macrophages in vitro. J Immunol Methods (1976) 0.84
Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst (1981) 4.60
Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect Immun (1985) 4.56
Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst (1977) 4.28
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet (2003) 3.23
Delayed hypersensitivity in the mouse. Adv Immunol (1975) 2.95
Comparison of 15 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages. J Clin Microbiol (1986) 2.94
Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med (2009) 2.48
Survival of herpes simplex virus in water specimens collected from hot tubs in spa facilities and on plastic surfaces. JAMA (1983) 2.20
Neural correlates of first-person perspective as one constituent of human self-consciousness. J Cogn Neurosci (2004) 2.16
Molecular cloning and carboxyl-propeptide analysis of human type III procollagen. Nucleic Acids Res (1984) 2.01
Split tolerance affecting delayed hypersensitivity and induced in mice by pre-immunization with protein antigens in solution. Clin Exp Immunol (1966) 1.99
Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci (1996) 1.87
Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions. J Immunol (1971) 1.76
Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID. EMBO J (1995) 1.76
Inhibition by streptomycin of tubercle bacilli within cultured human macrophages. Am Rev Respir Dis (1984) 1.74
Chromosomal localization of the human elastin gene. Am J Hum Genet (1985) 1.68
Environmental and developmental signals modulate proline homeostasis: evidence for a negative transcriptional regulator. Proc Natl Acad Sci U S A (1996) 1.65
Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence. Infect Immun (1982) 1.63
Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups. Heart (2006) 1.56
Glycopeptides of the type-common glycoprotein gD of herpes simplex virus types 1 and 2. J Virol (1983) 1.55
Environmental health training of promotoras in colonias along the Texas-Mexico border. Am J Public Health (2001) 1.51
Facial palsy: interpretation of neurologic findings. Laryngoscope (1978) 1.50
Human TAF(II)135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells. Genes Dev (1997) 1.47
Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum) Arch Otolaryngol Head Neck Surg (1988) 1.47
A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness. Nat Genet (1996) 1.45
An improved stain for immunodiffusion tests. J Immunol Methods (1977) 1.44
Inhibition by pyrazinamide of tubercle bacilli within cultured human macrophages. Am Rev Respir Dis (1986) 1.43
Natural mycobacteriostatic activity in human monocyte-derived adherent cells. Am Rev Respir Dis (1986) 1.42
Cycles of sex examined for environmental influences. Science (1993) 1.40
[Treatment of rectal carcinoma: satisfaction of general practitioners with surgical clinics]. Chirurg (2009) 1.39
Science is for the moment and truth is forever. Otolaryngol Head Neck Surg (1990) 1.39
Replication of lyophilized and cultured BCG in human macrophages. Am Rev Respir Dis (1983) 1.26
Preferential development by mice of delayed hypersensitivity to purified basic proteins. J Allergy (1968) 1.26
Adoptive transfer of immunologic tolerance into normal mice. J Immunol (1969) 1.25
Multiple interactions between hTAFII55 and other TFIID subunits. Requirements for the formation of stable ternary complexes between hTAFII55 and the TATA-binding protein. J Biol Chem (1996) 1.20
Investigation of the mechanisms by whick "enhancing" antiserum prevents induction of delayed hypersensitivity to protein antigens in mice. J Allergy (1969) 1.19
A new X linked recessive deafness syndrome with blindness, dystonia, fractures, and mental deficiency is linked to Xq22. J Med Genet (1995) 1.18
Non-syndromic X-linked mental retardation associated with a missense mutation (P312L) in the FGD1 gene. Clin Genet (2002) 1.18
Different internal metabolites trigger the induction of glycolytic gene expression in Saccharomyces cerevisiae. J Bacteriol (1995) 1.17
Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study. Ann Rheum Dis (2007) 1.15
Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system. J Infect Dis (1990) 1.13
The use of steroids in Bell's palsy: a prospective controlled study. Laryngoscope (1976) 1.12
Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size. Epidemiol Infect (2009) 1.09
Attempts to induce early-type ("Jones-Mote") delayed hypersensitivity in mice. J Immunol (1965) 1.06
Bell's palsy and the chorda tympani nerve: a clinical and electron microscopic study. Laryngoscope (1975) 1.05
Mouse pleural macrophages: characterization and comparison with mouse alveolar and peritoneal macrophages. J Reticuloendothel Soc (1982) 1.02
Enhancement of growth of Mycobacterium lepraemurium in macrophages by gamma interferon. Infect Immun (1989) 1.02
Pyrazinamide is not active in vitro against Mycobacterium avium complex. Am Rev Respir Dis (1986) 1.01
Homing in virtual environments: effects of field of view and path layout. Perception (1997) 1.01
Gold weight and wire spring implants as alternatives to tarsorrhaphy. Arch Otolaryngol Head Neck Surg (1987) 1.01
Measurement of glutathione levels in intact roots of Arabidopsis. J Microsc (2000) 1.01
Lymphokine-induced mycobacteriostatic activity in mouse pleural macrophages. Infect Immun (1982) 1.00
Role of MRI in the diagnosis of insufficiency fractures of the sacrum and acetabular roof. Skeletal Radiol (1997) 1.00
Rehabilitation of the crippled larynx: application of the Tucker technique for muscle-nerve reinnervation. Laryngoscope (1980) 0.99
Facial paralysis, peripheral type: a proposed method of reporting. (Emphasis on diagnosis and prognosis, as well as electrical and chorda tympani nerve testing). Laryngoscope (1970) 0.99
Thrombocytopenia in the neonatal lupus syndrome. Arch Dermatol (1988) 0.99
The effect of ethambutol on tubercle bacilli within cultured human macrophages. Am Rev Respir Dis (1985) 0.99
Two novel mutations confirm FGD1 is responsible for the Aarskog syndrome. Eur J Hum Genet (2000) 0.98
Studies on the induction and time course of repressionof delayed hypersensitivity in the mouse by low and high doses of antigen. Clin Exp Immunol (1970) 0.98
Preparatory electroimmunodiffusion for making precipitins to selected native antigens. Immunol Commun (1972) 0.97
Disturbing behavior: neurotoxic effects in children. Environ Health Perspect (2000) 0.96
"Ossifying" hemangiomas of the temporal bone: evaluation with CT. Radiology (1987) 0.96
The prognostic accuracy of the maximal stimulation test compared with that of the nerve excitability test in Bell's palsy. Laryngoscope (1971) 0.96
The combined effect of rifampin and pyrazinamide within the human macrophage. Am Rev Respir Dis (1992) 0.96
MRX8: an X-linked mental retardation condition with linkage to Xq21. Am J Med Genet (1992) 0.95
Genome-wide analysis of oral cancer--early results from the Cancer Genome Anatomy Project. Oral Oncol (2000) 0.94
Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera. J Cell Biol (1995) 0.94
Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: prospective data from the Caerphilly Study. Diabetologia (2002) 0.93
A hanging drop macrophage function test. J Reticuloendothel Soc (1978) 0.93
Total facial nerve exploration: transmastoid, extralabyrinthine, and subtemporal indications and results. Laryngoscope (1979) 0.93
Red chorda tympani nerve and Bell's palsy. Laryngoscope (1974) 0.92
Delayed hypersensitivity in mice to dextran. Int Arch Allergy Appl Immunol (1967) 0.92
Asymptomatic enophthalmos: the silent sinus syndrome. Am J Rhinol (2000) 0.92
The isolation of functionally heterogeneous hepatocytes of the proximal and distal half of the liver acinus in the rat. Hepatology (1986) 0.92
Combined effect of pyrazinamide and ofloxacin within the human macrophage. Tuber Lung Dis (1996) 0.92
Facial paralysis in children: differential diagnosis. Otolaryngol Head Neck Surg (1982) 0.92
Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy. J Cancer Res Clin Oncol (2015) 0.92
Sexual intercourse and risk of ischaemic stroke and coronary heart disease: the Caerphilly study. J Epidemiol Community Health (2002) 0.91
Anatomy of the facial nerve (spatial orientation of fibers in the temporal bone). Laryngoscope (1973) 0.91
Facial paralysis: differential diagnosis and indications for surgical therapy. Clin Plast Surg (1979) 0.91
Bell's palsy: results of surgery; salivation test versus nerve excitability test as a basis of treatment. Laryngoscope (1972) 0.91
Acute Bell's palsy: prognostic value of evoked electromyography, maximal stimulation, and other electrical tests. Am J Otol (1983) 0.91
Studies on the noradrenaline alpha-receptor. I. Techniques of receptor isolation. The distribution and specificity of action of N-(2-bromoethyl)-N-ethyl-1-naphthylmethylamine, a competitive antagonist of noradrenaline. Mol Pharmacol (1967) 0.90
Transferrin, iron, and serum lipids enhance or inhibit Mycobacterium avium replication in human macrophages. J Infect Dis (1993) 0.90
Neck masses in children: diagnosis and treatment. Pediatr Ann (1976) 0.90
Broadly reactive polymerase chain reaction for pathogen detection in canine granulomatous meningoencephalomyelitis and necrotizing meningoencephalitis. J Vet Intern Med (2012) 0.89
The role of immunologic tolerance in immunologic response. Ann Allergy (1966) 0.89
Lumbo-sacral chordoma with high-grade malignant cartilaginous and spindle cell components. Am J Surg Pathol (1990) 0.89
Trauma to the facial nerve. Otolaryngol Clin North Am (1983) 0.88
Culture conditions required for primary isolation and study of mouse blood monocytes. J Reticuloendothel Soc (1982) 0.88
Endoscopic sinus surgery: 4-year follow-up on the first 100 patients. Laryngoscope (1993) 0.88
Evans blue dye adjuvant enhances delayed hypersensitivity while blocking immunity to Mycobacterium tuberculosis in mice. Infect Immun (1981) 0.88
Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014. Intern Med J (2014) 0.88
Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma. J Urol (2011) 0.87
Characterization of a sheep elastin cDNA clone containing translated sequences. Biochem Biophys Res Commun (1984) 0.87
Studies on the noradrenaline alpha-receptor. II. Analysis of the "spare-receptor" hypothesis and estimation of the concentration of alpha-receptors in rabbit aorta. Mol Pharmacol (1967) 0.87
[Male circumcision is not associated with an increased prevalence of erectile dysfunction: results of the Cottbus 10,000-men survey]. Urologe A (2013) 0.87
Sequential invasive assessment of fetal renal function and the intrauterine treatment of fetal obstructive uropathies. Obstet Gynecol (1991) 0.86
[The significance of rebiopsy in the diagnosis of prostate cancer]. Urologe A (2009) 0.86